• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

室管膜瘤患者脑脊液中铂的峰值水平:两种不同顺铂给药方法的评估

Peak cerebrospinal fluid platinum levels in a patient with ependymoma: evaluation of two different methods of cisplatin administration.

作者信息

DeGregorio M, Wilbur B, King O, Wallenberg J, Prewitt S, Phillips J, Wilbur J

出版信息

Cancer Treat Rep. 1986 Dec;70(12):1437-8.

PMID:3791256
Abstract

Peak CSF and serum platinum levels were examined in a patient with ependymoma after each of four consecutive cisplatin doses of 100 mg/m2 administered by either 30-minute or 3-hour infusion. Both infusion lengths produced similar peak CSF platinum levels within 2 hours after the completion. Ultrafiltrate serum platinum levels correlated with the CSF platinum levels, whereas total plasma platinum did not. No differences in clinical toxicity or response were seen between the two methods of administration. Based on these preliminary results, similar peak CSF platinum concentrations are achieved by 30-minute or 3-hour infusions, and ultrafiltrate serum platinum concentrations can be used to predict these levels.

摘要

在一名室管膜瘤患者中,通过30分钟或3小时输注连续给予四次100mg/m²顺铂剂量后,检测了脑脊液(CSF)和血清铂的峰值水平。两种输注时长在输注结束后2小时内产生的CSF铂峰值水平相似。超滤血清铂水平与CSF铂水平相关,而总血浆铂则不然。两种给药方法在临床毒性或反应方面未见差异。基于这些初步结果,30分钟或3小时输注可达到相似的CSF铂峰值浓度,并且超滤血清铂浓度可用于预测这些水平。

相似文献

1
Peak cerebrospinal fluid platinum levels in a patient with ependymoma: evaluation of two different methods of cisplatin administration.室管膜瘤患者脑脊液中铂的峰值水平:两种不同顺铂给药方法的评估
Cancer Treat Rep. 1986 Dec;70(12):1437-8.
2
Ultrafiltrate and total platinum in plasma and cerebrospinal fluid in a patient with neuroblastoma.一名神经母细胞瘤患者血浆和脑脊液中的超滤液及总铂含量
Cancer Treat Rep. 1985 Dec;69(12):1441-2.
3
[Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin].[恶性胶质瘤和转移性脑肿瘤患者在选择性动脉内或静脉及颈动脉给予依托泊苷和顺铂后血浆和脑脊液中顺铂的药代动力学]
No Shinkei Geka. 1994 Jan;22(1):35-42.
4
Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.儿童顺铂持续或重复长时间输注:一项关于耳毒性、铂浓度及标准血清参数的前瞻性研究。
Pediatr Blood Cancer. 2006 Aug;47(2):183-93. doi: 10.1002/pbc.20673.
5
Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion.以连续5天输注方式给药的顺铂:血浆铂水平和尿铂排泄量
Cancer Treat Rep. 1986 Oct;70(10):1215-7.
6
[Pharmacokinetics of high-dose cisplatin administration (relationship between pharmacokinetics and administration schedule)].大剂量顺铂给药的药代动力学(药代动力学与给药方案之间的关系)
Hinyokika Kiyo. 1987 Nov;33(11):1760-5.
7
Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.顺铂脂质体包封剂型SPI-77的I期及药代动力学研究
Cancer Chemother Pharmacol. 2002 Mar;49(3):201-10. doi: 10.1007/s002800100371. Epub 2002 Jan 22.
8
Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates.非人类灵长类动物中静脉注射奥沙利铂、顺铂和卡铂的血浆及脑脊液药代动力学
Clin Cancer Res. 2005 Feb 15;11(4):1669-74. doi: 10.1158/1078-0432.CCR-04-1807.
9
[Cis-diamminedichloroplatinum penetration into the cerebrospinal fluid of the lateral ventricle, postoperative cavity, and lumbar subarachnoid space with or without pre-intravenous mannitol administration in patients with brain metastasis from lung cancer].[顺二氯二氨铂在伴有或不伴有静脉注射甘露醇预处理的肺癌脑转移患者侧脑室、术后腔隙及腰蛛网膜下腔脑脊液中的渗透情况]
Gan To Kagaku Ryoho. 2014 Mar;41(3):317-24.
10
Pharmacokinetic study of Cis-dichlorodiammine platinum II, in children after rapid infusion.顺二氯二氨合铂II在儿童快速输注后的药代动力学研究。
Biomedicine. 1981 Dec;34(3):146-53.

引用本文的文献

1
CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.中枢神经系统祖细胞和少突胶质细胞在体外和体内都是化疗药物的作用靶点。
J Biol. 2006;5(7):22. doi: 10.1186/jbiol50.
2
Direct delivery of platinum-based antineoplastics to the central nervous system: a toxicity and ultrastructural study.铂类抗肿瘤药物向中枢神经系统的直接递送:一项毒性和超微结构研究。
Cancer Chemother Pharmacol. 1993;31(6):449-54. doi: 10.1007/BF00685034.
3
A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors.
血脑屏障在人类脑肿瘤化疗中作用的批判性分析
J Neurooncol. 1994;20(2):121-39. doi: 10.1007/BF01052723.
4
Platinum-based chemotherapy for recurrent CNS tumours in young patients.铂类化疗用于年轻患者复发性中枢神经系统肿瘤
J Neurol Neurosurg Psychiatry. 1991 Aug;54(8):722-5. doi: 10.1136/jnnp.54.8.722.
5
Comparison of the cytotoxic activities of cisplatin and carboplatin against glioma cell lines at pharmacologically relevant drug exposures.在药理学相关药物暴露水平下顺铂和卡铂对胶质瘤细胞系的细胞毒性活性比较。
J Neurooncol. 1991 Aug;11(1):27-35. doi: 10.1007/BF00166994.
6
Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failure.高剂量静脉注射顺铂治疗氯乙基亚硝脲治疗失败后复发的成人恶性胶质瘤的II期评估。
J Neurooncol. 1992 Feb;12(2):187-91. doi: 10.1007/BF00172671.
7
Carboplatin combined with carmustine and etoposide in the treatment of glioblastoma.卡铂联合卡莫司汀和依托泊苷治疗胶质母细胞瘤。
Ital J Neurol Sci. 1992 Dec;13(9):717-22. doi: 10.1007/BF02229155.